# Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients

> **NCT03168308** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 92 (actual)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine w/ Glycopyrrolate

## Key facts

- **NCT ID:** NCT03168308
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-26
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03168308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03168308, "Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03168308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*